期刊文献+

Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus? 被引量:1

原文传递
导出
摘要 As a chronic systemic autoimmune disease,systemic lupus erythematosus(SLE)can influence multiple organs and systems.Although the pathological basis and risk factors for SLE have been extensively investigated,the exact pathogenesis of SLE remains to be explored.However,there is increasing evidence that T-cell−Bcell interactions promote the development of SLE,resulting in the generation of high-affinity antibodies[1].Tfh cells,a subgroup of T cells,can promote the formation of germinal centers,the maturation of B cells,and the differentiation of plasma cells[2].It has been found that multiple transcription factors(TFs)can regulate the generation of Tfh cells.For instance,B-cell lymphoma-6(BCL-6),an evolutionarily conserved zinc-finger protein,is an important positive transcription factor responsible for the differentiation and maturation of Tfh cells.In addition to maintaining the phenotype and GC response of Tfh cells,BCL-6 can also regulate the dynamics of T-cell−B-cell interactions and improve the efficiency of delivering help to B cells[3].
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2022年第7期863-865,共3页 中国免疫学杂志(英文版)
基金 This work was supported by grants from the National Natural Science Foundation of China(Nos.81830097,81972921) the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences(2021-RC320-001,2020-RC320-003) the Hunan Provincial Natural Science Foundation of China(No.2020JJ5849) the Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University(No.YX202101) Fundamental Research Funds for the Central Universities of Central South University(No.1053320216463).
  • 相关文献

参考文献2

二级参考文献3

共引文献3

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部